Skip to Content
  • Previous Rank815
  • Revenues ($M)$3,084
  • Revenue Percent Change18.4%
  • Profits ($M)$399
  • Profits Percent Change176.3%
  • Assets ($M)$13,253
  • Employees3,121
  • Market Value — as of March 31, 2017 ($M)$27,297
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Ludwig N. Hantson
CEO Title
Chief Executive Officer & Director
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New Haven, CT
Websitehttp://www.alexion.com
Years on Fortune 500 List-
Employees3,121

Alexion Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$3,08418.4%
Profits ($M)$399176.3%
Assets ($M)$13,253-
Total Stockholder Equity ($M)$8,694-
Market Value — as of March 31, 2017 ($M)$27,297-

Profit Ratios

Profit as % of Revenues12.9%
Profits as % of Assets3%
Profits as % of Stockholder Equity4.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.76
EPS % Change (from 2015)162.7%
EPS % Change (5 year annual rate)14.1%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2016)-35.9%
Total Return to Investors (5 year, annualized)11.3%
Total Return to Investors (10 year, annualized)28.3%